Viridian Therapeutics, Inc.\DE VRDN Earnings Call Transcripts

NASDAQ VRDN
$30.75 +0.56 (+1.85%)
As of: Nov 10, 2026 · 12:27 PM EST
1 earnings call on file for Viridian Therapeutics, Inc.\DE, Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Viridian Therapeutics, Inc.\DE Q3 2026 Earnings Call

Nov 4, 2026 6,255 words · 27 min read
  • Steve MahoneyPresident and Chief Executive Officer
  • Tony CascianoChief Commercial Officer
  • Seth HarmonChief Financial Officer
  • Greg RossinoSenior Director of Investor Relations
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Viridian Therapeutics, Inc.\DE Earnings Call Transcripts

Calls1
LatestNov 4, 2026
SinceQ3 2026

Fiscal 2026

All 1 Viridian Therapeutics, Inc.\DE transcript Register to get access to Viridian Therapeutics, Inc.\DE’s earnings call transcripts.